Allergopharma Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Corporate
  • Financing Rounds
  • 2

Allergopharma General Information

Description

Provider of allergy treatment products. The company operates in the field of allergen immunotherapy and offers high-dose, hypoallergenic, standardized products for the treatment of allergic diseases such as pollen and mite allergies.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Parent Company
Dermapharm
Primary Office
  • Hermann-Körner-Street 52
  • 21465 Reinbek
  • Germany
+49 040 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Allergopharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Allergopharma‘s full profile, request access.

Request a free trial

Allergopharma Executive Team (2)

Name Title Board Seat Contact Info
Philipp Maerz Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

Allergopharma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Allergopharma‘s full profile, request access.

Request a free trial